READ MORE PAXIL LEGAL NEWS
The study revealed that combining two different medications designed to combat depression could double the risk of miscarriage.
"These results, which suggest an overall class effect of selective serotonin re-uptake inhibitors, are highly robust given the large number of users studied," Dr. Anick Berard, who led the study, told the news source. "Physicians who have patients of child-bearing age taking antidepressants or have pregnant patients who require antidepressant therapy early in pregnancy discuss the risks and benefits with them."
It is estimated that more than one expectant mother in 30 takes an antidepressant with selective serotonin re-uptake inhibitors, meaning there are a number of pregnant woman whose children may suffer a heart defect.